novelex (previously forteq Healthcare) develops and manufactures complex medical devices that require high precision and technical production knowhow in clean room environments. The core competencies lie within complete customer solutions including the R&D phase, manufacturing and packaging solutions combined with high quality and service solution required by the pharma and laboratory industry.

Situation: Carve-Out
Investment Date: 2020
Location: Suisse
Industry: MedTech
Status: Exited (Trade-Sale)


Liberta Partners acquires a majority stake in MedTech company forteq Healthcare

Liberta Partners divests novelex AG to H&T Presspart, a Division of the Heitkamp & Thumann Group